Skip to content

25gr. Glucomedics vs 25gr. Zusto

25gr. Glucomedics vs 25gr. Zusto

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02607345
Enrollment
10
Registered
2015-11-18
Start date
2015-02-28
Completion date
2015-04-30
Last updated
2015-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

Objective: to compare blood glucose and insulin responses after consumption of 100ml water, sweetened with 25gr Zusto® and 100ml water sweetened with 25gr Glucomedics® (standard drink)

Detailed description

This is an experimental study enrolling 10 healthy female subjects. The study compares the blood glucose and insulin responses after consumption of 100ml water, sweetened with 25gr Zusto® and 100ml water sweetened with 25gr Glucomedics® (standard drink). Subjects need to be fasted for at least 8 hours before all visits. At visit 1, five women will consume the solution with 25gr Zusto®, the other five will have the solution with 25gr Glucomedics®. On visit 2, groups will be switched. Visit 1 and 2 will be performed within approximately one week interval. Both drinks will be identical in amount of water and only be different by the use of 25gr Glucomedics® and 25gr Zusto®. Before intake of the drink, vital signs, weight and bedside blood glucose and baseline blood samples - 15' and 0' for glucose, insulin and C-peptide will be taken at visit 1 and 2. Both drinks will be consumed within 5 minutes and time of start and end of intake of Zusto® / Glucomedics® will be documented. Blood samples for glucose, insulin and C-peptide will be taken at 15', 30', 60', 90', 120' and 180' after start of intake 25gr Zusto® and 25gr Glucomedics®.

Interventions

DIETARY_SUPPLEMENTZusto

25gr

DIETARY_SUPPLEMENTGlucomedics®

25gr

Sponsors

Bart Keymeulen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Female subjects * Age between 30 and 50 years * BMI between 20 and 30 kg/m²

Exclusion criteria

* No first degree relatives with mellitus type 1 or type 2 * No intake of medication with influence blood glucose levels * Pregnant, breast feeding or planning to become pregnant during the study * Employer of the investigator or study center with direct involvement in the proposed study or other studies under the direction of the investigator or study center

Design outcomes

Primary

MeasureTime frameDescription
the difference in glycemic index between 25gr. Zusto® and 25gr. Glucomedics®1 monthGI values will be calculated using the iAUC of Zusto® intake and Glucomedics® intake.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026